Zimmer Biomet Holdings, Inc. (ZBH)

Basic

  • Market Cap

    $24.65B

  • EV

    $30.07B

  • Shares Out

    208.98M

  • Revenue

    $7,279.2M

  • Employees

    18,000

Margins

  • Gross

    71.63%

  • EBITDA

    32.74%

  • Operating

    19.84%

  • Pre-Tax

    9.73%

  • Net

    6.52%

  • FCF

    8.89%

Returns (5Yr Avg)

  • ROA

    3.29%

  • ROE

    2.05%

  • ROCE

    6%

  • ROIC

    5.23%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $131.82

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $34.79

  • Earnings (Dil)

    $2.26

  • FCF

    $3.08

  • Book Value

    $59.86

Growth (CAGR)

  • Rev 3Yr

    1%

  • Rev 5Yr

    -1.7%

  • Rev 10Yr

    4.78%

  • Dil EPS 3Yr

    44.81%

  • Dil EPS 5Yr

    -23.4%

  • Dil EPS 10Yr

    -5.42%

  • Rev Fwd 2Yr

    5.28%

  • EBITDA Fwd 2Yr

    7.3%

  • EPS Fwd 2Yr

    7.38%

  • EPS LT Growth Est

    8.15%

Dividends

  • Yield

    —

  • Payout

    42.35%

  • DPS

    $0.96

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    2.1%

  • DPS Growth Fwd 2Yr

    0.49%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

7,932.9

7,982.2

6,127.5

6,827.3

6,939.9

7,279.2

Total Revenues % Chg.

1.7%

0.6%

-23.2%

11.4%

1.6%

5.6%

Cost of Goods Sold, Total

2,271.9

2,198.7

1,824.3

1,960.4

2,019.5

2,065.3

Gross Profit

5,661.0

5,783.5

4,303.2

4,866.9

4,920.4

5,213.9

Selling General & Admin Expenses, Total

3,372.4

3,278.6

2,525.4

2,626.4

2,667.6

2,768.0

R&D Expenses

391.7

449.3

322.8

435.8

406.0

453.4

Amortization of Goodwill and Intangible Assets

595.9

584.3

512.1

529.5

526.8

548.1

Other Operating Expenses, Total

4,360.0

4,312.2

3,360.3

3,591.7

3,600.4

3,769.5

Operating Income

1,301.0

1,471.3

942.9

1,275.2

1,320.0

1,444.4

Interest Expense, Total

-289.3

-226.9

-212.1

-208.4

-164.8

-193.5

Interest And Investment Income

—

—

—

—

—

—

Net Interest Expenses

-289.3

-226.9

-212.1

-208.4

-164.8

-193.5

Currency Exchange Gains (Loss)

-16.5

-14.4

-12.2

-5.5

-31.4

-1.2

Other Non Operating Income (Expenses)

—

-2.9

14.7

1.7

-124.8

-150.0

EBT, Excl. Unusual Items

995.2

1,227.1

733.3

1,063.0

999.0

1,099.7

Restructuring Charges

-34.2

-50.0

-107.2

-125.7

-191.6

-153.0

Merger & Related Restructuring Charges

-99.5

—

—

—

—

-7.9

Impairment of Goodwill

-975.9

—

-470.0

—

-289.8

-289.8

Gain (Loss) On Sale Of Investments

-6.0

—

—

—

—

116.8

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

3.0

In Process R&D Expenses

-3.8

-70.1

-33.0

-16.3

-3.0

-3.0

Legal Settlements

—

-52.7

-166.0

-201.0

-65.9

-35.0

Other Unusual Items

-146.9

-148.5

-62.3

-221.0

-45.2

-22.8

EBT, Incl. Unusual Items

-271.1

905.8

-105.2

499.0

403.5

708.0

Income Tax Expense

108.2

-225.7

-96.0

53.5

112.3

232.8

Earnings From Continuing Operations

-379.3

1,131.5

-9.2

445.5

291.2

475.2

Earnings Of Discontinued Operations

—

—

-128.2

-43.4

-58.8

—

Minority Interest

0.1

0.1

-1.5

-0.5

-1.0

-0.9

Net Income

-379.2

1,131.6

-138.9

401.6

231.4

474.3

Net Income to Common Incl Extra Items

-379.2

1,131.6

-138.9

401.6

231.4

474.3

Net Income to Common Excl. Extra Items

-379.2

1,131.6

-10.7

445.0

290.2

474.3

Total Shares Outstanding

204.0

206.0

207.6

209.0

209.0

209.0

Weighted Avg. Shares Outstanding

203.5

205.1

207.0

208.6

209.6

209.2

Weighted Avg. Shares Outstanding Dil

203.5

206.7

207.0

210.4

210.3

210.2

EPS

-1.9

5.5

-0.7

1.9

1.1

2.3

EPS Diluted

-1.9

5.5

-0.7

1.9

1.1

2.3

EBITDA

2,341.5

2,477.4

1,841.3

2,212.9

2,246.4

2,383.4